Patents by Inventor Magali B. HICKEY

Magali B. HICKEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aripiprazole formulations having increased injection speeds
    Patent number: 10085980
    Abstract: The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
    Type: Grant
    Filed: November 11, 2016
    Date of Patent: October 2, 2018
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Magali B. Hickey, Jennifer Vandiver
  • Pharmaceutical compositions comprising fatty acid esters
    Patent number: 10004807
    Abstract: The present invention relates to an injectable, pharmaceutical composition comprising a C1-6 alkyl ester of a C10-20 fatty acid. In an embodiment, the fatty acid is ethyl oleate, isopropyl oleate, ethyl myristate, or isopropyl myristate. These compositions are useful for the delivery of anti-psychotic drugs.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: June 26, 2018
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. Perry, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver
  • Pharmaceutical compositions comprising benzyl alcohol
    Patent number: 9999670
    Abstract: The present invention relates to a pharmaceutical composition comprising benzyl alcohol and polyoxyethylene derivatives of sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: June 19, 2018
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. Perry, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver
  • Pharmaceutical compositions comprising fatty glycerol esters
    Patent number: 9993556
    Abstract: The present invention relates to a pharmaceutical composition comprising glycerol esters of a fatty acid, wherein the compositions are useful for the delivery of anti-psychotic drugs.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: June 12, 2018
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. Perry, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver
  • Pharmaceutical compositions having improved storage stability
    Patent number: 9861699
    Abstract: The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent.
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: January 9, 2018
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver, Michael J. Palmieri, Jr., Zhengzheng Pan
  • Pharmaceutical Compositions Having Improved Storage Stability
    Publication number: 20180000944
    Abstract: The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent
    Type: Application
    Filed: September 14, 2017
    Publication date: January 4, 2018
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver, Michael J. Palmieri, JR., Zhengzheng Pan
  • Pharmaceutical Compositions Comprising Sorbitan Esters
    Publication number: 20170196856
    Abstract: The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
    Type: Application
    Filed: December 22, 2016
    Publication date: July 13, 2017
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver
  • ARIPIPRAZOLE FORMULATIONS HAVING INCREASED INJECTION SPEEDS
    Publication number: 20170157117
    Abstract: The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
    Type: Application
    Filed: November 11, 2016
    Publication date: June 8, 2017
    Inventors: Magali B. Hickey, Jennifer Vandiver
  • Benzoimidazol-2-yl pyrimidine modulators of the histamine Hreceptor
    Patent number: 9663497
    Abstract: Benzoimidazol-2-yl pyrimidines, purification methods for the same, and pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritus.
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: May 30, 2017
    Assignee: Janssen Pharmaceutica NV
    Inventors: Matteo Conza, Magali B. Hickey, Stefan Horns, Susanne Lochner
  • Aripiprazole formulations having increased injection speeds
    Patent number: 9526726
    Abstract: The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
    Type: Grant
    Filed: May 25, 2016
    Date of Patent: December 27, 2016
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Magali B. Hickey, Jennifer Vandiver
  • BENZOIMIDAZOL-2-YL PYRIMIDINE MODULATORS OF THE HISTAMINE H4 RECEPTOR
    Publication number: 20160340337
    Abstract: Benzoimidazol-2-yl pyrimidines, purification methods for the same, and pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritus.
    Type: Application
    Filed: August 3, 2016
    Publication date: November 24, 2016
    Inventors: Matteo Conza, Magali B. Hickey, Stefan Horns, Susanne Lochner
  • Aripiprazole formulations having increased injection speeds
    Patent number: 9452131
    Abstract: The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
    Type: Grant
    Filed: March 19, 2015
    Date of Patent: September 27, 2016
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Magali B. Hickey, Jennifer Vandiver
  • ARIPIPRAZOLE FORMULATIONS HAVING INCREASED INJECTION SPEEDS
    Publication number: 20160263111
    Abstract: The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
    Type: Application
    Filed: May 25, 2016
    Publication date: September 15, 2016
    Inventors: Magali B. Hickey, Jennifer Vandiver
  • Benzoimidazol-2-yl pyrimidine modulators of the histamine Hreceptor
    Patent number: 9434715
    Abstract: Benzoimidazol-2-yl pyrimidines, purification methods for the same, and pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritus.
    Type: Grant
    Filed: February 18, 2016
    Date of Patent: September 6, 2016
    Assignee: Janssen Pharmaceutica NV
    Inventors: Matteo Conza, Magali B. Hickey, Stefan Horns, Susanne Lochner
  • BENZOIMIDAZOL-2-YL PYRIMIDINE MODULATORS OF THE HISTAMINE H4 RECEPTOR
    Publication number: 20160159775
    Abstract: Benzoimidazol-2-yl pyrimidines, purification methods for the same, and pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritus.
    Type: Application
    Filed: February 18, 2016
    Publication date: June 9, 2016
    Inventors: Matteo Conza, Magali B. Hickey, Stefan Horns, Susanne Lochner
  • Pharmaceutical compositions comprising sorbitan esters
    Patent number: 9351976
    Abstract: The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: May 31, 2016
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver
  • PHARMACEUTICAL COMPOSITIONS HAVING IMPROVED STORAGE STABILITY
    Publication number: 20160136279
    Abstract: The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent
    Type: Application
    Filed: October 13, 2015
    Publication date: May 19, 2016
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver, Michael J. Palmieri, Zhengzheng Pan
  • Benzoimidazol-2-yl pyrimidine modulators of the histamine Hreceptor
    Patent number: 9278952
    Abstract: Benzoimidazol-2-yl pyrimidines, purification methods for the same, and pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritus.
    Type: Grant
    Filed: August 21, 2014
    Date of Patent: March 8, 2016
    Assignee: JANSSEN PHARMACEUTICA NV
    Inventors: Matteo Conza, Magali B. Hickey, Stefan Horns, Susanne Lochner
  • PHARMACEUTICAL COMPOSITIONS COMPRISING SORBITAN ESTERS
    Publication number: 20160038508
    Abstract: The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
    Type: Application
    Filed: April 16, 2015
    Publication date: February 11, 2016
    Inventors: Jason M. PERRY, Daniel R. DEAVER, Magali B. HICKEY, Julius F. REMENAR, Jennifer VANDIVER
  • Pharmaceutical compositions having improved storage stability
    Patent number: 9193685
    Abstract: The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent
    Type: Grant
    Filed: September 19, 2013
    Date of Patent: November 24, 2015
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver, Michael J. Palmieri, Jr., Zhengzheng Pan